Efficacy of both antibiotic and probiotic for control of necrotic enteritis in chickens experimentally

Document Type : Original researches

Abstract

Clostridium perfringens (C. perfringens) is the pathogenic bacterium caused necrotic enteritis (NE) which is the most threatening problem in poultry sector. This work aimed to study the occurrence of Clostridium perfringens, find out its in-vitro antibiotic sensitivity pattern to various antimicrobial drugs and the experimentally efficacy of antibiotic (amoxicillin) alone or including a probiotic against necrotic enteritis NE. The occurrence rate of C. perfringens in examined 150 tissue samples was 38.6%. Antibiogram analysis revealed that the organisms are very susceptible to amoxicillin (74.1%) followed by bacitracin (70.6%). Almost of isolates were multidrug resistant (MDR). Toxinotyping of C. perfringens isolates by PCR showed that all tested isolates belonged to C.perfringens type A. In the experiment, one day-old Cobb broiler (N=120) were divided into six equal-sized groups. Group (A) was provided with balanced ration without treatment (control negative), group (B) was fed on balanced ration and infected with C. perfringens (control positive), group (C) was infected with C. perfringens and treated with selected antibiotic (amoxicillin) in drinking water for 3 consecutive days by dose of 1gm/ L 24 hours post infection, group (D) was received probiotic in the drinking water from one day-old and then infected with C. perfringens, group (E) was received probiotic in the drinking water from one day-old and then infected with C. perfringens then treated with selected antibiotic (amoxicillin) by the same dose 24 hours post infection and group (F) was infected with C. perfringens and treated with selected antibiotic (amoxicillin) and probiotic by the same dose 24 hours post infection. The results showed that birds received probiotic displayed higher BW, BWG and most improved FCR over the whole rearing period. Chickens infected with C. perfringens had characteristic effect in hematological and biochemical parameters with significant decrease in total protein and HDL. The treated groups revealed significant improvement in above mentioned parameters. Experimentally infected chickens with C. perfringens developed atypically clinicopathological pictures of NE with 30% mortality. A milder disease picture has been recorded in treated groups with amoxicillin and or probiotic. According to our research, adding probiotic supplements to a chicken's diet can improve performance, gut health, and blood components to protect the bird against C. perfringens infection.

Keywords

Main Subjects


Efficacy of both antibiotic and probiotic for control of necrotic enteritis in chickens experimentally

   Sally H. Abou-Khadra1, Thoria A. Hamed2, Heba A. Ewis 3, Shaimaa H. Shaltot 4,  Dalia T. Mohamed *3,

Department of Bacteriology 1.4, Biochemistry 2 , Pathology and Clinical Pathology3, (Zagazig branch), Reference laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute (AHRI), Agricultural Research Centre (ARC), Dokki, Giza, Egypt.

Abstract:

Clostridium perfringens (C. perfringens) is the pathogenic bacterium caused necrotic enteritis (NE) which is the most threatening problem in poultry sector. This work aimed to study the occurrence of Clostridium perfringens, find out its in-vitro antibiotic sensitivity pattern to various antimicrobial drugs and the experimentally efficacy of antibiotic (amoxicillin) alone or including a probiotic against necrotic enteritis NE. The occurrence rate of C. perfringens in examined 150 tissue samples was 38.6%. Antibiogram analysis revealed that the organisms are very susceptible to amoxicillin (74.1%) followed by bacitracin (70.6%). Almost of isolates were multidrug resistant (MDR). Toxinotyping of C. perfringens isolates by PCR showed that all tested isolates belonged to C.perfringens type A. In the experiment, one day-old Cobb broiler (N=120) were divided into six equal-sized groups. Group (A) was provided with balanced ration without treatment (control negative), group (B) was fed on balanced ration and infected with C. perfringens (control positive), group (C) was infected with C. perfringens and treated with selected antibiotic (amoxicillin) in drinking water for 3 consecutive days by dose of 1gm/ L 24 hours post infection, group (D) was received probiotic in the drinking water from one day-old and then infected with C. perfringens, group (E) was received probiotic in the drinking water from one day-old and then infected with C. perfringens then treated with selected antibiotic (amoxicillin) by the same dose 24 hours post infection and group (F) was infected with C. perfringens and treated with selected antibiotic (amoxicillin) and probiotic by the same dose 24 hours post infection. The results showed that birds received probiotic displayed higher BW, BWG and most improved FCR over the whole rearing period. Chickens infected with C. perfringens had characteristic effect in hematological and biochemical parameters with significant decrease in total protein and HDL. The treated groups revealed significant improvement in above mentioned parameters. Experimentally infected chickens with C. perfringens developed atypically clinicopathological pictures of NE with 30% mortality. A milder disease picture has been recorded in treated groups with amoxicillin and or probiotic. According to our research, adding probiotic supplements to a chicken's diet can improve performance, gut health, and blood components to protect the bird against C. perfringens infection.

Key words: Probiotic, Clostridium perfringens, antibiotic, Immunoglobulin, chicken.

INTRODUCTION

          A common anaerobic bacterium that is easily found in soil, dust, excrement, feed, poultry litter, and intestinal contents is Clostridium perfringens, which is the source of the disease necrotic enteritis (NE). Broilers chickens that are 2 to 5 weeks old are most commonly affected. (Osman and Elhariri, 2013). Clostridium perfringens bacteria can infiltrate the delicate intestinal tissues of broilers attributable to their well-known endo- and exotoxins. When enterotoxins from C. perfringens bind to a protein called claudin and negatively affect birds, weight gain, FCR, and crude protein digestibility, the tight junction is broken and the barrier function is impaired (Saleh et al., 2023). The main toxin responsible for necrotic enteritis in chicken is the α -toxin (Timbermont et al., 2009). Due to cholangiohepatitis and intestinal mucosal necrosis, the disease is characterized by a decreased growth rate and low feed conversion rate. (Eraky and Abd El-Ghany, 2022). In the early stages of the disease, adequate antibiotic treatment may be able to control the infection (Lyras et al., 2009).

Since the use of antimicrobial feed additives for prevention has been restricted, NE has become more important (Opengart and Songer, 2013).

Recently, the economic production of safe chicken products without the use of antibiotics has been assisted by a number of natural alternative feed additives. Probiotic cultures have recently been used to maintain a healthy gut microbiome in humans and animals to prevent the attachment of harmful microbes, especially in the early stages of growth (Abd El-Hack et al., 2022). Furthermore, probiotic substances have good impacts on liver histopathology, intestinal morphology and histopathology besides a considerable reduction in both of their lesion ratings (Hussein et al., 2020). Additionally, probiotics can be used as supplements to achieve health benefits including hypocholesterolemia and lowering blood sugar since they have a considerable impact on biochemical markers (Abd Al-Fatah., 2020).  

Owing to the economic importance of this disease, this work was designed for isolation, identification , studying the antimicrobial susceptibility of C. perfringens isolated from chickens,  screening toxigenic attributes of circulating strains by multiplex PCR and evaluating the impact of dietary supplementation with probiotics and /or antibiotic on prevention of C.perfringens infection and reduction of NE severity as well as their effect on growth performance, hematobiochemical parameters and the pathological changes.

MATERIALS AND METHODS:

 Ethical approval

This study was declared by the Local Committee of the (ARC-IACUC) committee Institute: Animal Health Research Institute Ethical Committee Approval Number: ARC/AH/23/45.  All steps were carried out in accordance with the Animal Health Research Institute's recommendations in compliance with OIE criteria for the use of animals in research and teaching.

Samples 

A total of 150 intestinal samples from diseased broiler chickens aged from 2 to 5 weeks from different farms with history of diarrhea, depression and reduced growth performance were collected in the study. Samples were aseptically transferred in ice boxes for isolation and identification of C.perfringens in the Laboratory.

Bacterial isolation and identification:

Tissue samples were inoculated into tubes containing cooked meat medium (Oxoid, UK) (Willis, 1977) and incubated in anaerobic jar for 24 hrs at 37 oC. Aliquots of 0.1 ml were streaked over Perfringens agar (Tryptose Sulphite Cycloserine TSC Agar, Oxoid) and 10% sheep blood agar, each containing 200 ug/ml of neomycin sulphate then incubated anaerobically at 37 °C for 24 hrs (Carter and Cole, 1990). On blood agar, the C. perfringens colonies had a flat, olive color and a distinct double hemolysis zone, with the inner clear zone caused by beta toxin and the outside zone by alpha toxin (Vaikosen and Muller, 2001). Due to C. perfringens' capacity for sulphite reduction, colonies on TSC agar were black in colour. Gram positive non-motile bacilli were found through microscopic analysis. Biochemical identification of C. perfringens isolates showed catalase and indole negative, nitrate reduction positive, lecithinase (phospholipase C; α- toxin) activity on egg yolk Agar with opalescence (Cruickshank et al., 1975; Koneman et al., 1988 and Macfaddin, 2000).

Antibiogram

Antimicrobial susceptibility testing of isolates were applied by agar disk diffusion method according to British Society for Antimicrobial Chemotherapy (BSAC), (2011). The susceptibility testing were applied against antimicrobial agents of the commonly used in the field  amoxicillin (AX:10 μg), clindamycin (DA:2 μg) bacitracin (B:10 μg),  lincomycin (L:30 μg), amikacin (AK:30 μg), sulfamethoxazole/trimethoprim (SXT: 25 μg) neomycin (N:30 μg), cefotaxime (CTX:30 μg), ciprofloxacin (CIP:5 μg), spectinomycin (SPC:100 μg) and colistin  (CT: 10 μg ) by using commercial disks from Oxoid laboratories. In order to encourage the development of anaerobic bacteria, antimicrobial susceptibility tests were performed on 10% sheep blood agar media (Perelman et al., 1991).

Molecular characterization of C. perfringens toxigenic attributes

Tested isolates: eight C.perfringens isolates were randomly selected out of the twenty four isolates that demonstrated multidrug resistance phenotypes by agar disc diffusion for typing by PCR.

DNA extraction: QIAamp DNA mini kit (Qiagen, Germany, GmbH) was used.

Oligonucleotide primer: Primers were supplied from metabion (Germany), primers’ sequences; thermal profiles for PCR were shown in table (1).

PCR amplification: Multiplex PCR for C. perfringens toxins, primers were utilized in a 50- µl reaction containing 25 µl of EmeraldAmp Max PCR Master Mix (Takara, Japan), 1 µl of each primer of 20 pmol concentration, 12 µl of water, and 5 µl of DNA template. The reaction was performed in an Appliedbiosystem 2720 thermal cycler, Germany.

Analysis of the PCR Products

The products of PCR were separated by electrophoresis on 1.5% agarose gel (Applichem, Germany, GmbH). A generuler 100 bp ladder (Fermentas, thermo, Germany) were used to determine the fragment sizes. A gel-based documentation system (Alpha Innotech, Biometra) took pictures of the gel, and computer software was used to analyze the data.

Antibiotic

Amoxicillin: Arabcomox® obtained commercially from Arab Company, Egypt.  Each 100 gm contains Amoxicillin trihydrate 23 gm (equivalent to Amoxicillin base 20gm) by dose 1gm/ L drinking water for 3 days (recommended dose).

Probiotics

            Gro2max® obtained commercially from Bionatural America institute (USA) contains a source of live, naturally occurring microorganisms (Bacillus subtillis 7×106 CFU/gm, Lactobacillus acidophilus 3×106 CFU/gm, Pediococcus acidilactici 2×104 CFU/gm, Pediococcus pentosaceus 2×104 CFU/gm and Saccharomyces cervisiae 1× 106 CFU/gm) was used in a dose of 3.5 gm/gallon (3.8 L) in drinking water as recommended by the producer.

Bacterial inoculum (Bathhoko, 2009)

One of the PCR confirmed toxigenic C. perfringens type A isolated field strain in the current study was used in the challenge. At 19 days old; the birds were challenged via oral gavages by inoculation of 1ml of 1.5x108cfu daily, for 3 consecutive days [19th-20th –and 21st day of age].

 Experimental design:

One hundred and twenty; one day-old Cobb broiler chickens were divided into six equal groups (A, B, C, D, E and F) of 20 each. The chicks were vaccinated at 7th and 17th days with Newcastle and at 11th and 22th against Gumboro in drinking water. Group (A) was provided with balanced ration without treatment (control negative), group (B) was fed on balanced ration and infected with Closrtidium perfringens (control positive), group (C) was infected with C. perfringens and treated with selected antibiotic (amoxicillin) in drinking water for 3 consecutive days by dose of  1gm/ L 24 hours post infection, group (D) was received probiotic in the drinking water from one day-old by dose 3.5 gm/gallon  and then infected with C. perfringens, group (E) was received probiotic in the drinking water from one day-old by the same dose and then infected with C. perfringens then treated with selected antibiotic (amoxicillin) by the same dose 24 hours post infection and group (F) was infected with C. perfringens then treated with selected antibiotic (amoxicillin) and probiotic by the same dose 24 hours post infection. The chicks were reared on floor rearing, temperature was adjusted according to chicks age and subjected to drinking water and feed ad-libitum (NRC, 1994), for 38 days (the experimental period).

Count of C.perfringens

The intestinal tract of sacrificed birds of each group at 7 days post treatment was collected for bacterial count. Approximately 1-2 gram of intestinal contents from each of three birds from the challenged groups of chickens were collected, samples from each group were pooled for bacterial reisolation and count post challenge (Soad et al, 2015). Samples were diluted in buffered peptone water for an initial of 10-1 dilution, then tenfold serial dilutions were applied, one ml of each dilution was spread in duplicates of 10% sheep blood agar containing 200 ug/ml neomycin sulphate. All plates were incubated in gas pack anaerobic jar at 37˚C for 48 hours. Plates that produced 30-300 colonies were selected for enumeration. Count was expressed as log10 CFU per gram of intestinal contents, (Cruickshank et al., 1975).

Monitoring the Bird’s Growth Performance:

The body weight (BW) and the average daily feed intake (FI) were determined to calculate the body weight gain (BWG) and feed conversion ratio (FCR) at the end of each period (Cengiz et al., 2015).

Blood samples:

Blood samples were collected from wing vein puncture under aseptic precautions after 7 and 14 days post treatment. The first sample was 1 ml of blood collected on EDTA for hematological examination.  The second blood sample was 3 ml of blood taken without anticoagulant in a clean and dry centrifuge tube, left to clot at room temperature and centrifuged at 3000 rpm for 5 min. Serum samples were putted in dry clean capped tubes and kept in deep freeze at- 20ºC for biochemical analysis.  

The hematological studies:

Blood samples with anticoagulant were subjected for detection of cellular blood constituents according to Feldman et al. (2000).

Biochemical studies:

All biochemical parameters were measured using commercially available kits, and the manufacturer's manual's recommended technique was followed for each parameter. The liver transferases (alanine aminotransferase ALT and aspartate aminotransferase AST) activities were estimated according to Murray (1984). Serum uric acid was determined according to Sanders et al. (1980) and according to Henry (1974), the serum creatinine was estimated. Serum total protein was measured according to Tietz (1995). The procedure outlined by Lott and Turner (1975) was used to measure serum glucose. Immunoglobulin G (IgG) measured according to Dati (1989).  Total lipids analysis using commercially available kits from Diamond Diagnostics in Egypt, total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were tested calorimetrically per the manufacturer's instructions according to Saleh (2013).

Histopathological examination:

Samples of 3 cm long that obtained from intestine (1 cm cut from the midpoint), liver and kidney from each group were collected at 7th and 14th day post treatment. Tissue specimens were collected and flushed with phosphate buffered saline (PBS, pH 7.4), and fixed in neutral buffered formaldehyde (10%). The fixed specimens were processed by the conventional paraffin embedding technique including dehydration  through  graded concentrations of ethanol, clearing in 3 washes of xylene and melted paraffin, and finally embedding in paraffin wax at 65°C. 5µm thick sections were stained by Hematoxylin and Eosin   (Bancroft and Layton, 2013).and then stained sections were examined under light microscope.

Statistical analysis:

The analysis of variance (ANOVA) method of statistics was used. Differences in treatment mean were determined using Duncan's Multiple Range at a significance level of 0.05. The SPSS program was used to run all of the statistics (Kinnear and Gray, 2006).

 

Table (1): Primers sequences, target genes, amplicon sizes and cycling conditions.

Target bacteria

Target gene

Primers sequences

Amplified segment (bp)

Primary

Denaturation

Amplification (35 cycles)

Final extension

Reference

Secondary denaturation

Annealing

Extension

 

 

C. perfringens

Alpha toxin

GTTGATAGCGCAGGACATGTTAAG

402 bp

94˚C

5 min.

 

94˚C

30 sec.

 

55˚C

40 sec.

 

72˚C

45 sec. 

72˚C

10 min.

 

 

Yoo et al., (1997)

 

CATGTAGTCATCTGTTCCAGCATC

Beta toxin

ACTATACAGACAGATCATTCAACC

236 bp

TTAGGAGCAGTTAGAACTACAGAC

Epsilon toxin

ACTGCAACTACTACTCATACTGTG

541 bp

CTGGTGCCTTAATAGAAAGACTCC

Iota toxin

GCGATGAAAAGCCTACACCACTAC

317 bp

GGTATATCCTCCACGCATATAGTC

 

Results

Recovery rate of C. perfringens.

  1. perfringens was isolated from 58 of 150 pooled tissue samples (38.6%). Standard microbiological methods were used to identify them.

Antimicrobial susceptibility testing. 

Antimicrobial sensitivity profiling of the 58 confirmed C. perfringens isolates, indicated that higher rates of sensitivity to amoxicillin 43 (74.1%) followed by Bacitracin 41 (70.6 %), Amikacin 40 (68.9%) and clindamycin 39 (67.2%). On the other hand, out of examined isolates 42 (72.4%) were found resistant to Sulfamethoxazole/trimethoprim followed by (67.24%) to Colistin and (65.54%) to Neomycin (Fig. 1). All of the C. perfringens isolates under examination shown resistance to the common antimicrobials. Overall, results showed that most isolates were resistant to at least three of the tested antimicrobial agents from different groups, making them multidrug resistant (MDR). 

Figure (1): antimicrobial susceptibility profiles of C. perfringens isolates.

Toxinotyping of C. perfringens isolates by PCR.

Toxinotyping of isolates by PCR was applied on 8 randomly selected MDR C. perfringens isolates. PCR targeted the detection of toxigenic genes cpa gene encodes for alpha toxin, cpb gene encodes for beta toxin, εtx gene encodes for epsilon toxin and iA gene encodes for iota toxin, respectively. The results revealed that all (100%) of PCR examined isolates belonged to C. perfringens type A and produced positive PCR result for only cpa gene that encodes alpha toxin with the creation of a particular 402 bp amplicon. On the other hand, none of the 8 tested isolates was positive for cpb gene, etx gene, or iA gene (Fig. 2).

Figure (2): Multiplex PCR for Toxinotyping of C.perfringens isolates. Lane Neg.: negative control; (E.coli). lane POS: Positive control for C.perfringens type A with positive PCR result for cpα, cpβ, εtx genes and iA genes encode for alpha, beta, epsilon and iota toxins, with production of specific amplicons at 402 bp, 236 bp 541 bp and 317 bp, respectively, lane L: gene ruler ladder 100-1000 bp. Lanes 1- 8 : positive for cpa gene encodes for alpha toxin with production of specific amplicon at 402 bp.

Growth Performance parameters

The results concerning growth performance parameters of broiler chickens at starter, grower (preinfection) and finisher periods (postinfection) are presented in Table (2). During starter and growing periods, the BW and BWG of broiler chickens were significantly increased in groups (D&E). Broilers received probiotic in the drinking water showed improved FCR when compared with other experimental groups. At the end of experimental period, C. perfringens challenge caused significant growth retardation in all experimental groups, except for broilers received probiotic in the drinking water from one day-old compared to control positive group (B).

 

 

 

 

 

 

 

 

Table (2): Effect of antibiotic and or probiotic supplementation on growth performance under clostridia infection (M±S.E) (n=5).

Groups

parameters

Gr(A)

Gr(B)

Gr(C)

Gr(D)

Gr(E)

Gr(F)

Initial body weight (gm)

44±3.25

45±2.14

44±3.01

44.00±2.78

45±2.35

45±3.88

starter(1-10 days)

BW (g/bird)

266±16.95b

270±20.37b

250±17.14b

318±11.38a

315±12.08a

275±15.75b

BWG (g/bird)

222±16.53b

225±27.55b

206±18.95b

274±16.00a

270±14.22a

230±18.24b

FC

(g/bird)

414

420

398

425

415

400

FCR

1.86±0.08a

1.87±0.05a

1.93±0.03a

1.55±0.03b

1.54±0.04b

1.74±0.05a

Grower(11-22days)

BW (g/bird)

1100±6.20b

1115±16.96b

1110±19.30b

1210±14.44a

1200±20.57a

1135±14.66b

BWG (g/bird)

834±20.55b

845±17.15b

860±20.12ab

892±12.75a

885±17.92a

860±18.94ab

FC (g/bird)

1225

1232

1226

1120

1140

1210

FCR

1.47±0.17a

1.46±0.13a

1.42±0.17a

1.26±0.11b

1.29±0.09b

1.41±0.15a

Finisher(23-38 days)

BW (g/bird)

1895±30.00b

1630±40.48d

1820±25.49c

1980±25.45a

2030±37.41a

1925±25.00b

BWG (g/bird)

795±24.87ab

515±28.30d

710±21.32c

770±16.90b

830±17.92a

790±16.97b

FC (g/bird)

1800

1650

1750

1750

1800

1800

FCR

2.26±0.05c

3.20±0.06a

2.46±0.04b

2.27±0.04c

2.17±0.03d

2.28±0.03c

                 

Different letters at the same rows means that there was a significant change at p<0.05.

Hematological study

         The changes in Erythrogram and leukogram parameters were demonstrated in table (3) showed that the broilers infected with C. Perfringens resulted in significant decrease RBCs count, Hb concentration, TLC, heterophils and monocytes measures while lymphocytes showed significant decrease in infected group. A significant improvement in RBCs count, Hb content and leukogram in infected treated groups compared to the infected untreated group.

Table (3): Effect of antibiotic and or probiotic supplementation on Erythrogram and leukogram under clostridia infection at 7 and 14 days post treatment (M±S.E) (n=5).

 

Groups

parameters

At 7 days post treatments

At 14 days post treatments

Gr(A)

Gr(B)

Gr(C)

Gr(D)

Gr(E)

Gr(F)

Gr(A)

Gr(B)

Gr(C)

Gr(D)

Gr(E)

Gr(F

RBCs

x106 /µl

2.66ab±0.03

2.20c

±0.07

2.59b±0.04

2.55b±0.03

2.73a±0.04

2.62b±0.05

2.78a

±0.04

2.52c

±0.05

2.65b

±0.03

2.63b

±0.03

2.82a

±0.02

2.63b

±0.05

Hb

(gm/dl)

13.00b±0.23

12.58c±0.30

12.90b±0.18

12.66bc±0.21

13.65a±0.29

13.15b±0.15

13.67a

±0.25

12.90c

±0.37

13.25b

±0.25

13.28b

±0.36

13.75a

±0.33

13.28b

±0.29

PCV %

30.85±0.38

30.50±0.32

30.53±0.30

30.62±0.51

31.74±0.40

31.55±0.32

31.00

±0.55

30.95

±0.48

30.88

±0.44

31.15

±0.38

32.00

±0.50

31.05

±0.45

TLCx103 /µl

20.19c ±1.09

23.03a±1.15

22.52b±1.08

22.12b±0.48

20.75c±1.20

22.23b±0.98

20.56c±0.83

22.83a±1.05

22.74ab±1.28

22.30b±1.12

21.06c

±1.27

22.36b

±1.08

heterophilsx103 /µl

5.63d ±0.13

8.87a

±0.11

6.68b

± 0.44

8.00a

±0.15

6.15c

±0.38

6.75b

±0.22

5.50c±0.16

8.85a

±0.18

6.80b

± 0.21

8.70a

±0.25

6.08c

±0.09

6.33bc

±0.18

Lymphocytesx103 /µl

10.73b±0.38

9.22c

±0.25

11.73a ± 0.35

9.20c

±0.28

10.25b±0.40

11.23a±0.25

11.19a ±0.18

9.34c

±0.25

11.82a ± 1.08

8.98c

±0.30

10.85b±0.32

11.75a±0.48

Monocytesx103 /µl

2.75b ±0.06

3.82a

±0.08

3.00b ± 0.20

3.80a

±0.11

3.25b

±0.18

3.15b

±0.15

2.76c ±0.11

3.55a

±0.08

3.04b ±0.15

3.50a

±0.18

2.98b

±0.09

3.20ab

±0.15

Eosinophilsx103 /µl

1.08

±0.02

1.10

±0.01

1.11 ± 0.03

1.12

±0.01

1.10

±0.05

1.10

±0.03

1.11

±0.01

1.09

±0.03

1.08

± 0.04

1.12

±0.02

1.15

±0.01

1.08

±0.03

Different letters at the same row means that there was a significant change at p<0.05,

Biochemical study

       The impact of dietary supplementation with antibiotic and /or probiotics on serum biochemical parameters and lipid profile are documented in table (4) and (5) respectively. AST, ALT, uric acid, creatinine, glucose and IgG values revealed significant decrease in treated groups at 7 and 14 days post treatments compared with control positive group (B). While serum total protein showed significant increase in treated groups compared to control positive group (B). Lipid profile analysis (total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol) revealed significant improvement in the treated groups (D, E and F) compared to control positive group (B) at the two periods. Most of the mention parameters returned to the normal levels in treated groups ((D, E and F) compared to control negative group (A) at 14 days.

Table (4): Effect of antibiotic and or probiotic supplementation on some biochemical parameters under clostridia infection at 7 and 14 days post treatment (M±S.E) (n=5).

Groups

parameters

At 7 days post treatments

At 14 days post treatments

Gr(A)

Gr(B)

Gr(C)

Gr(D)

Gr(E)

Gr(F)

Gr(A)

Gr(B)

Gr(C)

Gr(D)

Gr(E)

Gr(F)

 

AST

U/L

93.4f

±0.3

191.60a

±0.9

 

147.1b

±1.3

135.90c±0.6

103.4e

±0.1

106.8d

±0.3

95.00d

±0.15

207.9a

±1.1

138.9b

±0.5

120.0c

±0.36

94.80d

±0.35

95.80d

±0.57

 

ALT

U/L

9.30e

±0.3

20.70a

±0.5

16.00b

±0.1

14.90c

±0.1

11.50d

±0.1

12.20d

±0.1

9.98d

±0.18

23.30a

±0.19

14.00b

±0.42

12.70c

±0.20

10.00d

±0.30

10.20d

±0.3

 

Uric acid

mg/dl

2.20f

±0.06

4.00a

±0.09

3.00b

±0.02

2.80c

±0.04

2.40e

±0.03

2.60d

±0.009

2.32c

±0.05

4.14a

±0.12

2.86b

±0.07

2.54c

±0.09

2.40c

±0.05

2.35c

±0.08

 

Creatinine

mg/dl

0.24e±

0.002

0.41a

±0.005

0.32b±

0.004

0.29c

±0.003

0.25d

±0.003

0.26d±

0.002

0.25c

±0.002

0.47a

±0.01

0.28b

±0.004

0.26c

±0.003

0.24c

±0.003

0.25c

±0.003

 

Total protein

g/dl

3.65a

±0.16

2.36e

±0.00

2.60d

±0.04

2.91c

±0.01

3.15b

±0.06

2.99b±

0.00bc

3.86a

±0.16

2.34c

±0.01

2.95b

±0.01

3.12b

±0.05

3.84a

±0.09

3.63a

±0.17

 

Glucose

mg/dl

180.6f

±0.7f

302.40a

±1.9

269.2b

±0.8

220.00c

±0.6

192.9e

±1.3e

206.1d

±2.5

181.3d

±0.8

290.8a

±7.9

243.4b

±4.9

210.3c

±0.40

190.9d±1.6d

192.10d

±1.7

 

IgG

mg/dL

493.2e

±1.3

714.90a

±6.2

652.9b

±1.8

610.80c±8.3

504.4de

±3.8

513.6d

±4.2d

493.7d

±1.3

711.4a

±6.4

565.8b

±8.7b

533.3c

±8.15

493.8d±1.5

495.20d

±2.2

 

Different letters at the same row means that there was a significant change at p<0.05,

Groups

parameters

At 7 days post treatments

At 14 days post treatments

Gr(A)

Gr(B)

Gr(C)

Gr(D)

Gr(E)

Gr(F)

Gr(A)

Gr(B)

Gr(C)

Gr(D)

Gr(E)

Gr(F)

Total Cholesterol

mg/dl

117.3e

±1.1

164.0a

±1.4

 

155.5b

±0.6

138.0c±0.7c

122.1d

±0.1

125.3d±1.6

117.90d

±1.10

164.90a

±1.38

149.7b

±0.05

132.4c±1.48

120.20d

±0.32

120.5d

±0.37

Triglyceride mg/dl

77.50e

±0.5

136.8a

±0.8

115.6b

±1.0

100.8c

±1.3

89.50d

±0.5

91.70d±0.4

78.10f

±0.59

140.50a±1.96

106.6b±1.77

98.30c

±0.80

83.00e

±1.34

87.30d

±1.36

LDL mg/dl

47.70f

±2.9

95.50a

±0.9

80.60b

±0.8

63.30c

±1.1

52.20e

±0.5

57.90d±0.1

48.10d

±3.04

96.10a

±1.08

77.70b

±1.01

59.20c

±1.80

47.80d

±2.74

49.00d

±2.03

HDL mg/dl

50.70a

±0.1

41.60e

±0.5

44.60d

±0.6

47.80c

±0.1

49.40b

±0.4

47.90c±0.2

51.10a

±0.33

40.90d

±0.65

46.50c

±0.68

48.80b

±0.26

49.90ab

±0.33

49.60b

±0.24

Table (5): Effect of antibiotic and or probiotic supplementation on Lipid profile under clostridia infection at 7 and 14 days post treatment (M±S.E) (n=5).

Different letters at the same row means that there was a significant change at p<0.05

 

Clinical Signs, Mortalities, gross Lesions and count of C. perfringens.

The clinical signs observed in infected group B (non-treated) post challenge with a toxigenic C. perfringens type A were severely decreased appetite, depression, emaciation, ruffled feather and brownish diarrhea. The severity of these signs was markedly decreased in the treated chickens especially those of group (E-F). The highest mortality rate was recorded in group B as 30%, followed by group C as 15%, group D as 10% and both groups (E &F) as 5% at 7th day post treatment. The macroscopic examination of chicken intestine in group B showed that small intestine was thin, dilated wall, filled with gas (Ballooning of intestine) and ulceration with some focal necrosis. These gross lesions were moderate in group D and very mild in groups E &F.

Concerning clostridial enumeration at 7th day post treatment revealed that, group (A) that was control negative showed clostridial count (2X103 CFU/ml). Group (C) treated with amoxicillin had clostridial count (5X105CFU/ml) lower than positive control group (B) which had (4X109 CFU/ml). Furthermore, the groups (E, F) (treated with antibiotic and prebiotics) had clostridial count (1X103 CFU/ml)  and (1.2X104 CFU/ml) respectively. Interestingly, group (D) received probiotic only had clostridial count (3X104 CFU/ml).  

Histopathological findings

The microscopical examination of intestine in group (B) (challenged-non treated) at 7th day post challenge revealed focal areas of necrotic enteritis invests an area of severe mucinous degeneration and congestion of submucosal blood vessels (Fig.3a). Focal colonization of microbial bacilli invaded submucosa was seen (Fig.3b), while liver appeared with severe congestion of hepatic blood vessels, perivascular fibrosis and cholestasis (Fig.3c). Hyperplasia of biliary epithelium, endotheliosis with periductal fibrosis were detected (Fig.3d). Kidney exhibited focal hemorrhagic areas at renal medulla (Fig.3e) .while intestine at 14th day post challenge showed complete degeneration of some intestinal villi (Fig.3f) and complete degeneration of some submucosal glands with sloughing of some intestinal villi (Fig.3g). Liver appeared with perivascular leucocytic cells infiltration (Fig.3h) while kidney at the same day showed congestion of renal blood vessels (Fig.3i). Organs of  infected chickens with clostridium perfringens    and treated with antibiotic group (C)  at 7th day post treatment showed some changes revealed intestine with  atrophy of some submucosal glands (Fig.4a). Liver with focal area of leucocytic cells infiltration (Fig.4b), and kidney with focal area of leucocytic cells infiltrate renal cortex (Fig.4c), while at 14th day post treatment intestine showed   fusion of some intestinal villi (Fig.4d). Liver with congestion of blood vessels and perivascular fibrosis (Fig.4e). Kidney with focal cystic dilation of some renal tubule (Fig.4f).  

 Organs of chickens treated with probiotic from 1st day then infected with clostridium perfringens group (D) showed intestine at 7th   day post treatment with mucinous degeneration of villus epithelium (Fig. 5a). Liver with severe congestion of blood vessels, normal tissue architecture and cellular details (Fig.5b), while   kidney showed renal cortex suffered congestion of blood vessels and inflammatory cells infiltration (Fig.5c). At 14th day post treatment revealed intestine with hyperplasia of submucosal glandular epithelium was detected (Fig. 5d). Liver exhibited mild congestion of blood vessels, endotheliosis and focal billary necrosis (Fig.5e). Kidney with degeneration of some renal tubules (Fig.5f).                               

Organs of chickens treated with probiotic from 1st day then infected with clostridium perfringens and treated with antibiotic group (E) at 7th   day post treatment revealed intestine with focal necrosis of some villus tips (Fig.6a) . Liver with diffuse congestion of blood vessels, perivascular fibrosis and dilated sinusoids (Fig.6b). Kidney showed focal area of renal degeneration represented in cloudy swellings (Fig.6c) while intestine at 14th day post treatment appeared with normal mucosa and submucosa. (Fig. 6d) and liver with mild congestion of blood vessels, focal area inflammatory cells infiltration (Fig. 6e) Kidney at the same day were apparently normal (Fig. 6f).

Organs of chickens infected with C. perfringens then treated with both antibiotic and probiotic group (F) at 7th day post treatment revealed intestine with   mild congestion of submucosal blood vessels (Fig.7a), while liver showed apparently normal tissue architecture and cellular details. (Fig.7b). Kidney showed mild congestion and mild atrophy of some renal glomeruli (Fig. 7c). Intestine at 14th day post treatment appeared with normal tissues of mucosa and submucosa (Fig. 7d). Liver showed normal tissue architecture and cellular details (Fig. 7e). Kidney appeared with focal areas of cloudy swellings (Fig.7f).

   Figure (3):Photomicrograph of H&E stained chickens organs infected with clostridium perfringens group (B) showing .( a) intestine at 7th day post infection (PI) with focal areas of necrotic enteritis(arrowhead) invests an area of severe mucinous degeneration (thin arrow) and congestion of submucosal blood vessels(thick arrow).( b) intestine at 7th day PI with focal colonization of microbial bacilli invaded submucosa (arrow) . (c ) liver at 7th day PI with severe congestion of hepatic blood vessels (arrow), perivascular fibrosis (arrowhead) and cholestasis (thick arrow).(d) liver at 7th day PI with hyperplasia of  bilary epithelium (arrowhead), endotheliosis (thin arrow) and periductal fibrosis(thick arrow). (e) Kidney at 7th day PI with focal hemorrhagic areas at renal medulla (arrow). (f) Intestine at 14th day PI with complete degeneration of some intestinal villi (arrows head). (g) Intestine at 14 th day PI with complete degeneration of some submucosal glands (arrows) and sloughing of some intestinal villi (arrowhead). (h) Liver at 14th day PI with perivascular leucocytic cells infiltration (arrowhead) ( i) kidney at 14th day PI with congestion of renal blood vessels(arrows) (scale bar=100µm).    Figure (4):Photomicrograph of H&E stained chickens organs infected with clostridium perfringens and treated with antibiotic gp.(C)  showing (a) intestine at 7th day post treatment with atrophy of some submucosal glands (arrows ).(b) liver at 7th day post treatment with focal area of leucocytic cells infiltration  (arrows) . (c) kidney at 7th day post treatment with focal area of leucocytic cells infiltrate renal cortex (arrow).(d) intestine  at 14th  day post treatment fusion of some intestinal villi (arrowhead).(e) liver at 14th day post treatment with congestion of blood vessels (arrow) and perivascular fibrosis(arrowhead).(f) kidney at 14th  day post treatment with focal cystic dilation of some renal tubules (arrow) (scale bar=100µm).

 

   Figure (5): Photomicrograph of H&E stained chickens organs treated with probiotic from 1st day then infected with clostridium perfringens gp.(D) showing (a) intestine at 7th   day post treatment with mucinous degeneration of villus epithelium (arrows head ). (b) Liver at 7th day post treatment with severe congestion of blood vessels (arrow) and normal tissue architecture and cellular details (arrows). (c) Kidney at 7th day post treatment with of renal cortex represented in congestion of blood vessels (arrow) and inflammatory cells infiltration (arrowhead). (d) Intestine at 14th day post treatment with hyperplasia of submucosal glandular epithelium (arrowhead). (e) Liver at 14th day post treatment with mild congestion of blood vessels (thin arrow), endotheliosis (arrowhead) and focal billary necrosis (thick arrow). (f) kidney at 14th day post treatment with degeneration of some renal tubules (arrows head) (scale bar=100µm).

 
Figure (6): Photomicrograph of H&E stained chickens organs treated with probiotic from 1st day then infected with clostridium perfringens and treated with antibiotic gp.(E) showing (a) intestine at 7th   day post treatment with focal  necrosis of some  villus tips (arrows head ). (b) Liver at 7th day post treatment with diffuse congestion of blood vessels (arrows head), perivascular fibrosis (thick arrows) and dilated sinusoids (thin arrow). (c) Kidney at 7th day post treatment with focal area of renal degeneration represented in cloudy swellings (arrows) (d) intestine at 14th day post treatment with normal tissues of mucosa and submucosa. (e) Liver at 14th day post treatment with mild congestion of blood vessels (arrowhead) and focal area inflammatory cells infiltration (arrow). (f) Kidney at 14th day post treatment with apparently normal renal cortex (scale bar=100µm).                                                                                                 Figure (7): Photomicrograph of H&E stained chickens organs infected with clostridium perfringens then treated with both antibiotic and probiotic gp.(F) showing (a) intestine at 7th   day post treatment mild congestion of submucosal blood vessels (arrow). (b) Liver at 7th   day post treatment with apparently normal tissue architecture and cellular details. (c) Kidney at 7th day post treatment with mild congestion (arrow) and mild atrophy of some renal glomeruli (arrowshead). (d) intestine at 14th  day post treatment with normal tissues of mucosa and submucosa. (e) liver at 14th  day post treatment normal tissue architecture and cellular details.(f) kidney at 14th day post treatment with focal areas of cloudy swellings (arrow) (scale bar=100µm). 

Discussion

In the poultry industry, one of the most critical problems is necrotic enteritis (NE) (Wang et al., 2017), because of severe economic losses and increased mortalities. Another significant aspect is that it is involved in food-borne intoxication, which evolved from consumption of different raw and canned foods, particularly chicken meat and meat products (Stringer, 2018).

In our study the recovery rate of C. perfringens was 38.6% which isolated from intestinal samples collected from diseased broiler chickens. These finding is in accordance to previous studies of EL-Helw et al., (2014) and Heidy et al., (2015) who stated C. perfringens prevalence rate 33.33%, and 45.9%, respectively. On the other hand these recovery rate lower than previous outcomes of Abd El-Hamid et al., (2015), Asmaa et al., (2017) and  Prerana et al., (2018), who recorded C. perfringens prevalence rates (70%), (65.1%) and (55.9%) respectively. These variances are rather typical when you consider the various management and sanitary practices and procedures used on various farms. Additionally, chickens with C. perfringens regularly shed it into the environment and poultry litter, which presents a risk of reinfection for chickens. In chickens and other animals, cross-infection through faeces, litter, waste from poultry, feed and water is a primary source of infection (Praveen et al., 2019). Furthermore, when hens have a concurrent clinical or subclinical coccidial infection in the gut, the prevalence of C. perfringens may considerably rise (Mohiuddin et al., 2016).

In the present study, antimicrobial sensitivity profiling of the 58 confirmed C. perfringens isolates, indicated that higher rates of sensitivity to amoxicillin  (74.1%) followed by Bacitracin  (70.6 %) and Amikacin (68.9%). these results nearly similar to the published data from Salem et al. (2020). Amoxicillin is believed to be the most effective treatment for chickens infected with C. perfringens, according to other studies conducted in the United States, China, and Norway (Llanco et al., 2012).  On the other hand, 72.4% of examined isolates were resistant to Sulfamethoxazole/trimethoprim followed by 67.24% to Colistin and 65.54% to Neomycin. Similarly, Gad et al., (2011) recorded highest resistance against neomycin and colistin but found that most C. perfringens strains were sensitive to Sulfa trimethoprim. Also, Prerana et al., (2018) found that 86.8% of isolates were resistant to colistin. The resistance of examined isolates to sulfa-trimethoprim agreed with those obtained by Llanco et al., (2012) and Osman and Elhariri, (2013).  Our results illustrated that the overall examined isolates were resistant to at least 3 of the tested antimicrobial agents from different groups, making them multidrug resistant (MDR) which agreed with study results of Osman and Elhariri (2013). The discrepancy in the resistance pattern from one study to another can be attributed to the differences in C.perfringens exposure to different levels of antibiotic stress ( as feed additive ,prophylaxis and therapeutic agent) in different localities.

One of the typical commensals in the intestinal flora of both humans and animals is C. perfringens. Therefore, it is important to distinguish between toxic and non-toxic strains. In this regards, toxigenic attributes of 8 isolates that had multidrug resistant phenotypes were studied by multiplex PCR. PCR results revealed that all examined isolates (100%) belonged to C.perfringens type A that carry cpa gene, encodes for alpha toxin beside to absence of other major lethal toxin genes. These results were in accordance with the findings of Eaftekhar et al., 2023 and Salem et al., (2020). Van Immerseel et al., (2009) reported that alpha toxin was the major virulence factor in the pathogenesis of necrotic enteritis in poultry.

The present study was designed to investigate the efficacy of amoxicillin and probiotic in control of necrotic enteritis in broiler , the clinical signs of infected chicken showed depression, emaciation, sever decrease appetite, ruffeled feather  and brownish diarrhea which  agree with ( Islam, et al.,2009, Saleh,.,et al .,2011, Abd El-hamid  et al., 2015, Wafaa et al., 2022)   , These clinical signs may be due to the effect of colistridium toxins (Anders , 2006). The main characteristic lesion is necrosis at the intestinal level, whose clinical signs include depression, dehydration,  diarrhea, and a decreased food consumption also lesions are observed throughout the gastrointestinal tract  with the presence of gas and occasionally, lesions occur in other organs like  liver, and kidney these results were similar to previous studies by  Van Immerseel et al., (2009), Cooper et al.,(2013), Paiva et al.,(2014) and Caly et al.,(2015).

 Our results showed that the highest mortality rate (30%) with highest clostridial count (4X109) were recorded in infected non treated group (B) that matched with Umar et al., (2018) and lower than recorded in previous studies by Aboubaker and Elbadawy (2017) and Salem et al., (2020) who recorded mortality rate 40% and 50%, respectively .It's possible that the effects of C. perfringens' toxins are to blame for the mortalities observed in infected birds (Sameh et al., 2005). On contrary, Pedersen et al., (2008) reported that there is no mortality detected during experimentally infected with C. perfringens and only a transient colonization with challenge strains had been obtained. Also, Malmarugan et al. (2010) showed that a C. perfringens infection trial with chickens exhibited no clinical symptoms of NE and no deaths. Vijay and Dustan, (2007) attributed these differences in mortalities caused by C. perfringens infection were due to many stresses factor that birds are exposed to it as wet litter, high temperature, ventilation management, crowdedness, type of ration and other management protocols. On the other hand, amoxicillin treated group (c) had mortality rate (15%) with clostridial count (5X105) which lower than recorded in infected non treated group (B). these finding can be justified as a result to antimicrobial effect in suppression of C. perfringens and decreased its intestinal colonization which lead to prevention of necrotic enteritis as mentioned by Watkins et al., (1997).

The current findings show that dietary supplementation with probiotic displayed higher BW, BWG and most improved FCR over the whole rearing period these results correlated with Hussein et al (2020) and Shah et al (2021). Dietary inclusion of probiotics significantly increased body weight gain (BWG) and improved feed conversion ratio (FCR) during the starter and overall periods in Japanese quails (Siadati et al., 2017).

Herein, the groups (E, F) (treated with antibiotic and probiotics) had mortality rate 5% with clostridial count (1X103 CFU/ml)  and (1.2X104 CFU/ml) respectively. These results agree with the published data from Sokale et al (2019) who found that the supplementation of broiler chicks with Bacillus subtilis alone resulted in improved production, growth performance and reduced mortality after a C. perfringens challenge. Therefore, supplementation with Bacillus subtilis can not only be used to control NE diseases but also enhances gut health in broiler chicks (Jayaraman et al., 2013). Clostridium perfringens infection has been evidenced to decrease feed efficiency and increase gut lesions (Injured mucosa) leads to decreased digestion and absorption, reduced weight gain and increased feed conversion ratio and mortality rates, which account for higher productive losses in poultry (Van Immerseel et al., 2009). Using multi-strain probiotics appears to be the most effective strategy to increase the effects of probiotics. These probiotics have a positive impact on the host by strengthening growth-promoting bacteria in the intestinal tract, which is combined with a viable antibiosis of harmful bacteria (Lukic et al., 2017). The biological role of probiotics in the change of intestinal pH may be responsible for the improvement of all performance metrics since it benefits the bacterial population, enhances nutrient absorption, and boosts feed utilization efficiency. (Dunne 2001).

The hematological parameters changes in broilers suffering from necrotic enteritis might be due to bacterial toxin (Liu et al., 2010). The decrease in erythrogram might be due to intravascular hemolysis induced by C. perfringens (Topley and Wilsons 1999), also Allam et al., (2013) reported that Clostridial toxins caused breakdown of phospholipids of erythrocytes membrane and cause hemolysis by damaging circulating erythrocytes. A significant improvement in RBCs count and Hb content of C. Perfringens infected broilers then treated with amoxicillin and/or probiotic and compared to the infected non treated group. Nagaralli et al., (2002) Saied that amoxicillin act by inhibition of cell wall mucopeptide biosynthesis during bacterial multiplication. Mikkelsen et al., (2009) mentioned that C. perfringens growth was suppressed by organic acids supplementation. Our results agree with El-Gharbawy (2014) and Sayed et al., (2016) in which an improvement of erythrogram parameters in C. Perfringens infected broilers then treated with amoxicillin or probiotic were detected.

Variations of leukogram in our study may be due to the bacterial infection and inflammation that lead to leukocytosis, heterophilia and monocytosis (Nasr El –Deen et al., 2019). Our results were matched with Gheith et al., (2011) and Saleh et al., (2011) who reported that a leukocytosis and heterophilia as a characteristic feature of in C. Perfringens infected broilers. Treated birds with amoxicillin or probiotic or with a combination of amoxicillin and probiotics showed improvement in the leukogram compared to non-treated group. Similar results were also obtained by El-Shahat (2014) and El-Sheikh et al., (2018). The immune system has been demonstrated to benefit from taking probiotics in a number of ways, including increased lymphocyte, macrophage, and natural killer (NK) cell activity, increased heterophil oxidative burst, and increased immunoglobulin synthesis. The usage of probiotics, which  help  to  stabilize  the  stomach  and  regulate  the  immune  system,  may  help  to  maintain  a  healthy  balance between anti-inflammatory and pro-inflammatory cytokines (Shumaila et al., 2022). In light of these findings, it has been found that probiotics may increase the quantity of intestinal epithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) in the small intestine while also preventing the growth of pathogenic microorganisms (Dhama and Singh, 2010).

Regarding to the recorded results of serum biochemical parameters. Infected non treated group revealed significant increase in all biochemical parameters with significant decrease in total protein and HDL. The liver enzymes (AST and ALT) activities were increased in C.perfringens infected group (B) which may be due to  denoting hepatic damage and biliary stasis caused by clostridial toxins (Nasr El –Deen et al., 2019). Serum uric acid and creatinine were significantly increased in infected non treated group that may be a result of renal injury and cellular necrosis. As renal tubule degeneration inhibited the excretion of uric acid and creatinine, their levels in the serum of infected birds increased. (Nasr El –Deen et al., 2019). Similar results obtained by (Allam et al., 2013 and Saleh et al., 2023). Hypoproteinemia observed in infected non treated group may be due to the decreased feed intake, the loss through the intestine and the kidneys, or may be due to liver damage by clostridial toxins. The treated groups with amoxicillin and or probiotic revealed significant improvement in serum biochemical parameters of the challenged groups. Diet supplementation with Bacillus subtilis and E. faecium results in normal liver function as a result of a significant decrease in the ALT and AST activities in the blood (Hatab et al., 2016). On the other hand Hussein (2014) found that probiotics (Saccharomyces cerevisiae) did not have any significant effect on serum AST and ALT activities in broiler chicks fed a supplemented diet compared to the control group. Also probiotics decrease urease activity in gut subsequently, reducing the concentration of non-protein nitrogen, uric acid, ammonia and urea that result in lowering the ammonia formation in litter (Abd Al-Fatah 2020). While serum uric acid levels were significantly increased with the increasing of probiotics levels in broiler (Sultan and Abdul- Rahman 2011). However, there were no any changes in kidneys of mice that treated with probiotics may be as a result to serum uric acid level was at tolerance level (Salahuddin et al., 2013).

Glucose is an important cellular source of energy and serves as a metabolic substrate (Nahavandinejad et al., 2014). Significant increase in serum glucose level in infected non treated group also detected by Nasr El –Deen et al., (2019). Regarding to effect of probiotics on blood glucose levels, our results conflict with Hussein et al., (2020) found that serum glucose was highest when probiotics were used against Clostridium perfringens infection in broiler chickens. Some studies investigated a significant improvement in blood glucose level after ingestion of probiotics for weeks (Ejtahed et al., 2012). Shah et al., (2021) added that probiotic treatments significantly low­ered plasma glucose levels compared to treatment by antibiotic growth promoters. While IgG recorded the high values for control positive group. IgM and IgG isotypes are indicators for resistance of diseases in poultry (Star et al., 2007). Probiotics have a significant role in development of immune response against Newcastle disease, tetanus toxoid and Clostridium perfringens alpha-toxin (Haghighi et al., 2006). Llanco et al., (2012) suggested amoxicillin was effective against necrotic enteritis infection. The inclusion of native and commercial probiotics had a significant effect on serum glucose, total protein, globulin, uric acid, LD and LDL/HDL ratio of Japanese quails (Siadati et al., 2017). Probiotics’ diverse roles in sup­pressing cancer, lowering serum glucose, and lowering serum cholesterol are leading to increased accep­tance of probiotics (Adhikari and Kim 2017 ). Shah et al (2021) detected minor depletions in levels of total cholesterol, HDL, and triglycerides in broiler supplemented with probiotic. Dibaji et al., (2012) found that feeding probiotics decreased serum LDL, but not HDL levels in broilers. On the other hand, Hussein et al (2020) found that total protein, lipids and albumin in broiler chicks was not affected by probiotic supplementation.

Important information on the condition of the digestive tract can be gleaned from the small intestine's structure. (Teirlynck et al., 2009).For proper food absorption and the development of the gut microbiota, the mucosa and intestinal villi with their microvilli are vital, while the mucosa and microbiota, together with the gut-associated lymphoid tissue (GALT), provides an immune complex that will work as a gastric defense mechanism. Alshamy et al., (2018), Sun and Jia (2018) discovered that aggressiveness towards any of these elements, particularly during the first few weeks of life, could cause changes to the integrity of the intestinal epithelium, nutritional bioavailability, and absorption, fostering an inflammatory response inside the gut.

The histopathology of C. perfrigenes experimentally infected chicken revealed necrotic enteritis with submucosal congestion and degeneration of intestinal villi similar to that obtained by (Abd El-hamid et al., 2015, Abd El-Ghany et al., 2022) .Caly et al.,(2015) who found that the infected broiler chickens showed severe lesions of the small intestine presenting a degenerated mucosa. Congestion of blood vessel and flattening of villi in the lamina propria and submucosa have also been noted. Subsequently, there is a necrosis in the intestinal mucosa and villi of infected broiler chickens that noted by Mora et al.,(2020). Hussein et al., (2020) reported that broiler chickens challenged with Clostridium showed signs of injury to intestine tissue, including the degeneration and necrosis of intestinal villi.

 However, in our result these histopathological effects were significantly improved in chickens of group E and F the intestinal tissue appeared with normal mucosa and submucosa, then C and D respectively. These results are also in accordance with the note of Llanco, et al., (2012); Sarker, et al., (2013) and Lensing et al., (2010) that proved the efficacy of   amoxicillin in controlling of necrotic enteritis infection. However, the assumption that probiotics can protect the body from gut diseases by enhancing gut immunity Vieira et al.,(2013), improving gut development Chen et al.,(2015), and altering gut microbiota  Ubeda et al.,(2012) has been well accepted with our result especially in combination with the antibiotic.

 The liver of infected non treated group showed cholestasis with inflammatory cell infiltrations and congestion of hepatic blood vessel. These results were similar to those obtained by   Cooper et al., (2009).  In our results we showed hyperplasia of bilary duct these result similar to that recorded with Mora et al .,(2020) ,Van Immerseel et al.,(2009), Redondo et al.,(2016), Smyth et al.,(2016) who found that the histopathological lesions can be observed in the intestinal tract, including ulcers, bile duct hyperplasia, and inflammation. The chronic subclinical disease process allows bacteria to reach the bile duct and bloodstream, therefore, the pathogen can be found in the liver. The bacterial infection is the most important cause of lobular localization and may be a preamble to hepatocyte necrosis Gkretsi et al.,(2007) . Our results are partial in agreement with Hussein et al.,(2020) who found that the liver of chicks challenged with Clostridium were associated with several hepatocellular damages, including the congestion of portal blood vessels with numerous lymphocytic aggregations, as well as edema and coagulative necrosis . The liver in group D (treated with probiotic) normal tissue architecture and cellular details with mild congestion of blood vessels. Hussein et al (2020) reported that a normal hepatocellular structure with mild perivascular lymphocytic aggregation in broiler chicks with probiotic supplementation. The supplementation of probiotics may enhance the enrollment of pro-inflammatory immune cells to systemic lymphoid tissues, including the liver and other organs Gkretsi et al., (2007). Moreover, the role of probiotics on the transfer of immune cells in the liver was reported by Zhang et al., (2008). The liver showed mild congestion of blood vessels and small focal aggregation of inflammatory cells in some cases of group E and F while in the most cases the liver showed apparently normal tissue architecture and cellular details which indicates that the combination of the antibiotic and or the probiotic in drinking water, are effective in restoring the drawbacks of NE on liver and this improvement agree with our clinicobiochemical results.

The presence of nephrotoxicity was confirmed by the histopathological results of kidney which showed congestion of renal blood vessels and hemorrhage in infected non treated group, the histopathological lesions of kidney were significantly improved with amoxicillin treatment in combination with probiotic in group E and F. the supplementation of probiotics significantly improves the intestinal health and decreases the histological damage caused by C. perfringens these result similar to the results obtained by Menconi et al .,(2020). Our histopathological results showed that the applied antibiotic was the most effective on the control of chickens infected with C. Perfringens   which accords with   Abd El-hamid et al.,(2015) and Wafaa et al., (2022).

Conclusion

  1. perfringens infection in broiler chickens induced adverse effects on growth performance, hemato-biochemical and immumological profile of birds which could be reversed or ameliorated by using amoxicillin and or probiotic which had a beneficial effect in control of the infection. So, the study recommended the use of probiotic not only promote the growth of chickens but also it helps in the prophylaxis against bacterial infection hand in hand with antibiotics.

 

Conflict of interest: none.

Abd Al-Fatah M. 2020. Probiotic Modes of Action and Its Effect on Biochemical Parameters and Growth Performance in Poultry. Iranian Journal of Applied Animal Science . 10(1), 9-15.
Abd El-Ghany WA, Abd El -latif MA, Hosny F, Alatfeehy NM, Noreldin AE, Quesnell  RR,  Robet Chapman Sakai, Land Elbestawy AR. 2022. Comparative efficacy of postbiotic , probiotic, and antibiotic against necrotic enteritis in broiler chickens. Poultry Science 101:101988.
Abd El-Hack ME,. El-Saadony ME, Elbestawy AR, El-Shall NA, Saad AM, Salem HM. 2022. Necrotic enteritis in broiler chickens: disease characteristics and prevention using organic antibiotic alternatives − a comprehensive review. Poult. Sci. 101:101590.
Abd El-Hamid HS, Ellakany HF, Bekhit AA, Elbestawy A,  Rand SB. 2015. Clinical and laboratory studies on chicken isolates of Clostridium perfringens in Egypt. J. World's Poult. Res. 5 (2): 21-28.
Aboubaker M,  Elbadawy M. 2017. Efficacy of Flagymox (Amoxicillin and Metronidazole combination) in controlling Clostridium perfringens infection in broiler chickens. World journal of pharmacy and pharmaceutical sciences. 6, (1), 80-95.
Adhikari PA, Kim WK. 2017. Overview of prebi­otics and probiotics: Focus on performance, gut health and immunity-a review. Ann. Anim. Sci., 17(4): 949-966.
Allam HH, Nahad AG, Abdullaha SH, Dina MM. 2013. Immuno- Biochemical and pathological studies on necrotic enteritis in pekin duckling with trial of treatment. J Mansoura Vet Med, XV(1): 211-226.
 Alshamy Z, Richardson KC, Hünigen H, Hafez HM, Plendl J, Al Masri S. 2018. Comparison of the gastrointestinal tract of a dual-purpose to a broiler chicken line: A qualitative and quantitative macroscopic and microscopic study. PLoS ONE 2018, 13, e0204921.
Anders J. 2006. Clostridium perfringens the causal agent of necrotic enteritis in poultry. Ph D. Thesis. Faculty of Veterinary Medicine and Animal Science. Department of Biomedical  Sciences and Veterinary Public Health. Uppsala Swedish University of  Agricultural Sciences.
Asmaa S, Sahar AZ, Youssef IY, Basma S. 2017. The incidence of C. perfringens in chickens in different seasons and Governorates in Egypt. Journal of veterinary medical research, 24 (1): 12-20.
Bancroft JD, Layton C. 2013. The hematoxylin and eosin. Pages 179-220 in Theory and Practice of Histological Techniqes .SK Suvarna, C Layton and JD Bancroft, eds.7th ed. El Sevier, Churchill Livingstone, Pennsylvania.
Bathhoko T D. 2009. Performance of Clostridium perfringens challenged broiler chickens inoculated with effective microorganisms. msc agric. (animal science), faculty of natural and agricultural science, Pretoria Univ. BSAC. Version 10.2. Birmingham, United Kingdom.
British Society for Antimicrobial Chemotherapy (BSAC). 2011. Methods for antimicrobial susceptibility testing, Version 10.2, May 2011. BSAC, Birmingham, United Kingdom.
 Caly DL, D’Inca R, Auclair E, Drider D. 2015. Alternatives to antibiotics to prevent necrotic enteritis in broiler chickens: A microbiologist’s perspective. Front. Microbiol. 6, 1336 
Carter GR, Cole JR. 1990. Diagnostic procedures in veterinary bacteriology and mycology.” 5th Ed., Academic Press, Harcourt, BoaceJov. Publisher, New York, Boston, Tokyo, Toronto.
Cengiz Ö, Köksal BH, Tatlı O, Sevim Ö, Ahsan U and Üner AG.2015. Effect of dietary probiotic and high stocking density on the performance, carcass yield, gut microflora, and stress indicators of broilers. Poultry Science ; 94(10):2395-2403.
Chen GO, Sleman SMB, Mingan C, Paul AI. 2015. Novel probiotics: their effects on growth performance, gut development, microbial community and activity of broiler chickens. Anim Nutr  1:184–91.
Cooper KK, Songer JG, Uzal FA. 2013. Diagnosing clostridial enteric disease in poultry. J. Vet. Diagnostic Investig. , 25, 314–327
Cooper KK, Trinh HT and Songer JG. 2009. Immunization with recombinant alpha toxin partially protects broiler chicks against experimental challenge with Clostridium Perfringens. Veterinary Microbiology: ,133: 92–97.
Cruickshank R, Duguid JR, Marmion BP, Swain, RHA. 1975. Textbook of medical microbiology, 12 ed Churchill, Livingstone, Edinburgh and New York.
Dati F, Lammers M, Adam A, Sontag D, Stienen L. 1989.
Reference value for 18 plasma proteins on the Behring
Nephlometer System .Sonderdruck Lab. Med. Clin. Immunoassay,
13: 87.
Dhama K, Singh SD. 2010. Probiotics improving poultry health and production:an overview. Poultry Punch, 26, 41.
Dibaji SM, Seidavi A, Asadpour L. 2012. Effect of dietary inclusion of the symbiotic Biomin IMBO on broilers’ some blood metabolites, research opinions.Animal & Veterinary Sciences .2:10-13.
Dunne C. 2001. Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder. Inflamm. Bowel Dis. 7, 136–145.
Eaftekhar A R, Tanvir A N, Md Sayedul Islam, Himel B, Md Zohorul Islam. 2023. "Phenotypical Identification and Toxinotyping of Clostridium perfringens Isolates from Healthy and Enteric Disease-Affected Chickens", Veterinary Medicine International, vol. 2023, Article ID 2584171, 8 pages, 2023. https://doi.org/10.1155/2023/2584171
Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. 2012. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 28, 539-543.
El-Gharbawy E. 2014. Concurrent use of amoxicillin and metronidazol for controling clostirdial problems in broiler chickens. M.Sc. 414 S. M. El-Sheikh, M. H. Khairy, N. Z.H. Eleiwa, O. E. Abdalla, A. G. Abd El-Monsef Thesis Fac. of Vet Med. (Pharmacology) Monefia University.
EL-Helw H, El- Sergany E, Abdalla Y, Taha M M, Lashin A I, El-Meneisy A A. 2014. Role of Clostridium perfringens type A as a causative agent of necrotic enteritis in Turkey. Veterinary Medical Journal- Giza, 60 (2):1-22.
El-Shahat IE. 2014. Concurrent use of amoxicillin and metronidazole for controlling clostridial infection in broiler chickens. M.V.Sc. Thesis. Pharmacology Department, Faculty of Veterinary Medicine, El-Sadat University.
El-Sheikh, S.M.; Khairy, M.H.; Eleiwa, N.Z.E.; Osama, E.A. and Abd ElMonsef, A. G. (2018). Effect of sanguinarine phytobiotic, sodium butyrate compared to ampicillin on controlling necrotic enteritis in broiler chickens. Slov Vet Res, 55(20): 405–414.
Eraky R.D, Abd El-Ghany WA. 2022. Genetic characterization, antibiogram pattern, and pathogenicity of Clostridium perfringens isolated from broiler chickens with necrotic enteritis. J.Indonesian Trop. Anim. Agric. 47:1–16.
Feldman BF, Zinkl JK, Jain NC. 2000.  Schalm Vet. Hemato. 5th Ed., Philadelphia, Lippincott Willams, and Wikins; 1120-1124.
Gad W, Hauck R, Krüger M,  Hafez H M. 2011. Prevalence of Clostridium perfringens in commercial turkey and layer flocks. Arch. Geflügelk., 75 (2): 74 -79.
Gheith I, Fararh K, Bakry H, Hosney G. 2011.  Clinicopathological effect of probiotics on enteric diseases in broiler chicks. J Benha Vet Med, 22(2): 25-34.
 Gkretsi V, Mars WM, Bowen WC, Barua L, Yang Y, Guo L, St-Arnaud R, Dedhar  S, Wu C, Michalopoulos GK. 2007.  Loss of Integrin Linked Kinase from Mouse HepatocytesIn VitroandIn VivoResults in Apoptosis and Hepatitis. Hepatology , 45, 1025–1034. [CrossRef
Haghighi HR, Gong J, Gyles CL, Hayes MA, Zhou H, Sanei B, Chambers JR, Sharif S. 2006. Probiotics stimulate production of natural antibodies in chickens. Clin. Vaccine Immunol. 13, 975-980.
Hatab M, Elsayed,M, Ibrahim N.2016. Effect of some biological supplementation on productive performance, physiological and immunological response of layer chicks. J. Radiat. Res. Appl. Sci.  9, 185–192.
Heidy A E, Amany E, Sherif M, Mohamed R. 2015. Typing of Clostridium Perfringens Isolates Recovered from Necrotic Enteritis in Turkeys in Egypt by Multiplex PCR. International Journal of Research Studies in Biosciences (IJRSB) Volume .ISSN 2349-0357.
Henry RJ 1974. Determination of serum creatinine. Clinical Chemistry: Principles and technics. 2nd Ed., Harper and Row. P 548-551.
Hussein A. 2014. Effect of biological additives on growth indices and physiological responses of weaned Najdi ram lambs. J. Exp. Biol. Agric. Sci. 2, 6.
Hussein E O S,  Ahmed SH,  Abudabos AM, Aljumaah MR, Alkhlulaifi  MM, Nassan MA, Suliman GM, Naiel MAE,  Swelum AA. 2020. Effect of Antibiotic, Phytobiotic and Probiotic Supplementation on Growth, Blood Indices and Intestine Health in Broiler Chicks Challenged with Clostridium perfringens, Animals .10, 507.
Islam MN, Rashid SMH, Juli MSB, Hoque MF, Akter MR. 2009. Necrotic enteritis in chickens: pathological, bacteriological and therapeutical investigation. J Int Sustain Crop Prod 4(3): 1-7.
Jayaraman S, Thangavel G, Kurian H, Mani R, Mukkalil R, Chirakkal H. 2013. Bacillus subtilis PB6 improves intestinal health of broiler chickens challenged with Clostridium perfringens-induced necrotic enteritis. Poult. Sci. 92, 370–374.
Kinnear P,Gray C. 2006.  SPSS 12 Made Simple. Psychololgy,  press.
Koneman EW, Auen SD, Dowell VR, Sommers HM. 1988. Color atlas and text book of diagnostic microbiology. 2nd Ed. J.B. Lip Co, NewYork, London.
Lensing M, Van Der Klis JD, Fabri T, Cazemier A, Else AJ. 2010. Efficacy of a lactylate on production performance and intestinal health of broilers during a subclinical Clostridium perfringens infection. Poul Sci, 89(11): 2401–2409.
Liu D, Guo Y, Wang Z, Yuan J. 2010.  Exogenous lysozyme influences Clostridium perfringens colonization and intestinal barrier function in broiler chickens. Avian Pathol. 39: 17–24. 47. Doxy D. Clinical pathology and diagnostic procedure 2 nd Ed. Baillier London.1983; 56–60.
Llanco LA, Viviane N, Ferreira AJ and Avilacampos MJ. 2012. Toxinotyping and antimicrobial susceptibility of Clostridium perfringens isolated from broiler chickens with necrotic enteritis. International Journal of Microbiology Research,4, 290-294.
Lott JA, Turner K. 1975. Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin  Chem. Nov; 21(12), 1754-60.
Lukic J, Chen V, Strahinic I, Begovic J, Lev-Tov H, Davis SC, Tomic-Canic M, Pastar I. 2017.  Probiotics or pro-healers: The role of beneficial bacteria in tissue repair. Wound Repair Regen, 25, 912–922.
Lyras D, O’Connor JR, Howarth PM, Sambol SP, Carter G P, Phumoonna T, Rood JI.  2009. Toxin B is essential for virulence of Clostridium difficile. Nature, 458(7242): 1176-1179.‏
MacFaddin JF. 2000. Biochemical tests for dentification of medical bacteria. Baltimore: Lippincott Williams & Wilkins; 1-450. 39 pp. 1781–1791.
Malmarugan S, Sivaseelan S, Eswaran M A, Balasubramaniam G A, Dorairajan N. 2010. Responses of broiler chickens orally challenged with Eimeria acervulina and Clostridium perfringens or infected alone with Clostridium perfringens. Indian Journal of Veterinary Pathology, 34(2):134-137.
Menconi A, Sokale AO, Mendoza SM, Whelan R, Doranalli K. 2020. Effect of Bacillus subtilis DSM 32315 under different Necrotic Enteritis models in broiler chickens: A meta-analysis of 5 independent research trials. Avian Dis.
Mikkelsen LL, Vidanarachchi JK, Olnood CG, Bao YM, Selle PH, Choct M. 2009. Effect of potassium diformate on growth performance and gut microbiota in broiler chickens challenged with necrotic enteritis. Br Poult Sci, 50(1): 66–75.
Mohiuddin M, Iqbal Z, Rahman SU. 2016. Prevalence of Clostridium  perfringens [Beta] 2-toxin in sheep and goat population in Punjab, Pakistan. Thai J. Vet. Med. 2016, 46, 491.
Mora ZV, Macías-Rodríguez ME, Arratia-Quijada J, Gonzalez-Torres YS, Nuño K, Villarruel-López A.2020. Clostridium perfringens as Foodborne Pathogen in Broiler Production: Pathophysiology and Potential Strategies for Controlling Necrotic Enteritis. Animals (Basel);10(9):1718.
Murray R. 1984. Alanine aminotransferase.Kaplan LA., Clin Chem The C.V. Mosby Co. St Louis. Toronto. Princeton.1088-1090.
Nagaralli B, Seetharamappa J, Melwanki M. 2002. Sensitive spectrophotometric methods for the determination of amoxicillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations. J Pharma Biomed Anal, 29(5): 859-864.
Nahavandinejad M, Seidavi A, Asadpour L, Payan-Carreira R. 2014. Blood biochemical parameters of broilers fed di_erently thermal processed soybean meal. Rev. MVZ Córdoba, 19, 4301–4315.
Nasr El-Deen NAN, Gamal El-Din IM, Khodary MR. 2019. Effect of Experimental Clostridium perfringens Infection on Some Immunological, Hematological and Biochemical Values in Broiler Chickens  . Zag Vet J, Volume 47, Number 2, p. 222-233
NRC 1994. Nutrient requirement of poultry, 9th rev. edn (Washington, DC, Narional Academy Press).
Opengart K, Songer JS. 2013.  Necrotic Enteritis Diseases of Poultry. In diseases of poultry. 13th ed.: Swayne, D. E., Glisson JR, McDougald LR, Nolan Lisa K., Suarez, D. L. and Venugopal Nair. Ames, IA, USA: Iowa State Press; BBpp. 949-953.
Osman KM, Elhariri M. 2013. Antibiotic resistance of Clostridium perfringens isolates from broiler chickens in Egypt. Rev Sci Tech. 32(3):841-50.
 Paiva D, McElroy A. 2014. Necrotic enteritis: Applications for the poultry industry. J. Appl. Poult. Res., 23, 557–566.
Pedersen K, Bjerrum L, Heuer OE, Lo Fo Wong DM, Nauerby B. 2008. Reproducible infection model for C. perfringens in broiler chickens. Avian. Dis.;52(1):34-39.
Perelman B, Mints S, Zjut M, Kuttin E, Machny S. 1991. An unusual Clostridium colinum infection in broiler chicken. Avian Pathol, 20 (3):475 - 480.
Praveen Kumar N, Vinod Kumar N, Karthik A. 2019. Molecular detection and characterization of Clostridium perfringens toxin genes causing necrotic enteritis in broiler chickens. Trop. Anim. Health Prod. 2019, 51, 1559–1569.
Prerana R, Shelke Mrunalini M, Pawade Prashant P, Mhase Prajwalini V, Mehere, Jyotika D S. 2018. Antibiotic Sensitivity and Histopathological Study of Clostridium.
 Redondo LM, Redondo EA, Delgado F, La Sala LF, Fernández Miyakawa ME. 2016. An Experimental Reproduction of Necrotic Enteritis in Broiler Chickens. J. Vet. Sci. Med. 4, 1–5.
Salahuddin M, Akhter H, Akter S, Miah M, Ahmad N. 2013. Effects of probiotics on haematology and biochemical parameters in mice. Bangladesh Veterinarian. 30(1), 20-24.
Saleh A A. 2013. Effects of fish oil on the production performances, polyunsaturated fattyacids and cholesterol levels of yolk in hens. Emir. J. Food Agric. 1, 605–612.
Saleh AA, Hafez A, Amber K, Abdelhady AY,  Heba M, Salem H M, Fathy M, Kamal MA, Alagawany M, Alzawqari MH. 2023. Drug‑independent control strategy of clostridial infection in broiler chickens using anti‑toxin environmentally friendly multienzymes, Scientific Reports 13:5614.
Saleh N, Fathalla SI, Nabil R, Mossad AA. 2011. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers. J Anaerobe, 17(6): 426-430.
Salem SM, Mustafa DI, Hamed R I, El-Azzouny MM, Anwar N. 2020. Assessment of Pathological Changes of Mixed Infection of Coccidiosis and Necrotic Enteritis In Turkey. j. Egypt. vet. med. Assoc80(1), 55-84.‏
Sameh M, Nasser A, Gehan G. 2005. Efficacy of metronidazole, clindamycin and the probiotic in Clostridium perferingens infection in chickens.4th Int .Sci.Conf. Mansoura. (pp. 1393-1205).
 Sanders GTB, Pasman AJ, Hoek FJ. 1980. Determination of serum uric acid. Clin. Chem. Acta, 101: 299-303.
 Sarkar,. M, Ray JP, Mukhopadhayay SK, Niyogi D, Ganguly S. 2013. Study on Clostridium perfringens type A infection in broiler of west Bengal, India. J The IIOAB, 4(4): 1-3.
Sayed A, Sabry M, Osama E, Sarhan M. 2016. Concurrent use of ciprofloxacin and metronidazole for controlling of some bacterial infections in broiler chickens. Benha Vet Med J, 2016; 31, 2: 83– 92.
 Shah SMT, Islam MT, Zabin R, Roy PC, Meghla NS, Jahid IK. 2021. Assessment of novel probiotic strains on growth, hematobiochemical parameters, and production costs of commercial broilers in Bangladesh, Veterinary World, 14(1): 97-103.
Shumaila Y, Hafiz M N, Ibrar A, Sabir H,Muhammad W, Shahid N, Muhammad T, Ozge S, Muhammad FZ Ch. 2022. A review of probiotic applications in poultry: improving immunity and having beneficial effectson production and health. postępy mikrobiologii – advancements of microbiology2022, 61, 3, 115–123.
Siadati SA, Ebrahimnezhad Y, Salehi Jouzani GH,  Shayegh J. 2017. Evaluation of Probiotic Potential of Some Native Lactobacillus Strains on the Growth Performance and Serum Biochemical Parameters of Japanese Quails (Coturnix Coturnix Japonica) during Rearing Period.
Smyth JA. 2016. Pathology and diagnosis of necrotic enteritis: Is it clear-cut? Avian Pathol.  45, 282–287.
Soad S, Belih Zeinab M Labib, Aml M Ragab. 2015. Role of Saltose Probiotic for the Control of the Experimental Infection of the Clostridium Perfringens and the Coccidia in Chickens Alexandria Journal of Veterinary Sciences 46 (1): 20 - 41. 
Sokale A, Menconi A, Mathis G, Lumpkins B, Sims M, Whelan R, Doranalli K.2019. Effect of Bacillus subtilis DSM 32315 on the intestinal structural integrity and growth performance of broiler chickens under necrotic enteritis challenge. Poult. Sci. 98, 5392–5400.
Star L, Frankena K, Kemp BMG, Nieuwland B, Parmentier, HK. 2007. Natural humoral immune competence and survival in layers. Poult Sci, 86(6): 1090–1099.
Stringer MF. 2018. “Clostridium perfringens type A food poisoning,” in Clostridia in Gastrointestinal Disease, pp. 117–138,CRC Press, Boca Raton, Florida, 2018.
Sultan K, Abdul-Rahman S. 2011. Effect of probiotic on some physiological parameters in broiler breeders. Int. J. Poult. Sci. 10, 626-628.
Sun X, Jia Z. 2018. Microbiome modulates intestinal homeostasis against inflammatory diseases. Vet. Immunol. Immunopathol.  205, 97–105.
Teirlynck E, Bjerrum L, Eeckhaut V, Huygebaert G, Pasmans F, Haesebrouck F, Dewulf J, Ducatelle R, Van Immerseel F. 2009.The cereal type in feed inflfluences gut wall morphology and intestinal immune cell infifiltration in broiler chickens. Br. J. Nutr. 102:1453–1461.
Tietz N W. 1995. Clinical Guide to Laboratory Tests, 3rd ed Philadelphia; W. B. Saunders.
Timbermont L, Lanckriet ., Gholamiandehkordi AR, Pasmans F, Martel A, Haesebrouck F. 2009. Origin of Clostridium perfringens isolates determines the ability to induce necrotic enteritis in broilers, Comp. Immunol. Microbiol. Infect. Dis. 32(6):503 -512.
Topley Y, Wilsons T. 1999.  Microbiological and Microbial Infections 9 th Ed. Vol 3 Systemic bacteriology Oxford Univ. Press, USA. 1999; 52: 237–8. 49.
Ubeda C, Pamer EG. 2012. Antibiotics, microbiota, and immune defense. Trends Immunol  33:459–66.
Umar S, Younus M, Shahzad M, Aqil K, Qayyum R, Mushtaq A, Ali MA, Tanveer MM. 2018.Role of Wheat Based Diet on the Pathology of Necrotic Enteritis in Turkeys. Hindawi Publishing Corporation. Scientifica, 2016. understanding of the pathogenesis of necrotic enteritis in chickens. Trends. Microbiol. 17 (1): 32-36.
Vaikosen ES, Muller W. 2001.Evaluating biochemical tests for isolation and identification of Clostridium perfringensgens in fecal samples of small ruminants in Nigeria. BullAnim Health and production in Africa, 49(4): 244-248.
Van Immerseel F, Rood JI, Moore RJ, Titball RW. 2009. Rethinking our understanding of the pathogenesis of necrotic enteritis in chickens. Trends Microbiol. 17, 32–36.
Vieira AT, Teixeira MM, Martins FS. 2013. The role of probiotics and prebiotics in inducing gut immunity. Front Immunol . 4:445.
Vijay D, Dustan C. 2007. Necrotic enteritis prevention and control. Avian advice newsletter. 9 (2).
Wafaa A A, Mervat A A, Fouad H, Nayera M A, Ahmed E N, Rebecca R Q, Robert C, Lisa S, Ahmed RE. 2022. Comparative effificacy of postbiotic, probiotic, and antibiotic against necrotic enteritis in broiler chickens. Poultry Science 101:101988.
Wang H, Ni X, Qing X, Liu L, Lai J, Khalique A, Li G, Pan K, Jing B, Zeng D. 2017. Probiotic enhanced intestinal immunity in broilers against subclinical necrotic enteritis. Front. Immunol. 2017, 8, 1592.
Watkins KL, Shryock R, Dearth N, Saif Y. 1997. In-vitro antimicrobial susceptibility of Clostridium perferingens from commercial turkey and broiler chicken origin. Veterinary Microbiology, 54 (2):195-200. ‏
Willis AT. 1977. Anaerobic Bacteriology, Clinical and Laboratory Practice. 3rd  Ed., Butter Worth, London, Boston; p. 131-133
Zhang W, Wen K, Azevedo MS, Gonzalez A, Saif LJ, Li G, Yousef AE, Yuan L. 2008. Lactic acid bacterial colonization and human rotavirus infection influence distribution and frequencies of monocytes/macrophages and dendritic cells in neonatal gnotobiotic pigs. Vet. Immunol. Immunopathol.  121, 222–231.